U.S. Health Care REITs Stock News

Earlier this week, Merck reported that the FDA approved KEYTRUDA and KEYTRUDA QLEX, each in combination with WELIREG, as adjuvant therapy for adults with clear cell renal cell carcinoma at intermediate-high or high risk of recurrence following surgery, based on disease‑free survival gains in the Phase 3 LITESPARK‑022 trial. This decision introduces the first approved pairing of a PD-1 inhibitor with a HIF-2α inhibitor and extends WELIREG into earlier-stage kidney cancer, broadening Merck’s...

In recent days, Ryan Specialty Holdings reported weaker-than-expected fourth-quarter and full-year 2025 results, while also facing securities law investigations and hosting its investor presentation at the Morgan Stanley US Financials Conference 2026 in New York. At the same time, a mix of analyst downgrades, securities law scrutiny, and increased insider share purchases has put a spotlight on how confident management really is in the company’s long-term prospects. We’ll now examine how...

Needham’s new Buy rating on Hyliion Holdings (HYLN) has thrown a spotlight on the stock, with the firm highlighting the commercialization prospects for the KARNO power module and a debt-free balance sheet. See our latest analysis for Hyliion Holdings. Hyliion’s recent move follows a sharp re-rating, with the stock posting a 30 day share price return of 106.13% and a year to date share price return of 306.59%. The 1 year total shareholder return stands at 410.34%. If Hyliion’s surge has your...

Synchrony Financial (SYF) is back in focus after expanding its co brand partnership with Lowe’s and rolling out CareCredit across Pet Resort Hospitality Group locations, while recent monthly credit data points to steady portfolio performance. See our latest analysis for Synchrony Financial. The recent partnerships with Lowe’s and Pet Resort Hospitality Group, combined with steady credit metrics, come as the stock trades at US$73.36 after a 15.02% 90 day share price return, while the 3 year...

Virgin Galactic Holdings has recently redeemed about US$30.5 million of its 9.80% First Lien Notes by issuing roughly 6.73 million shares and filed a US$46.86 million shelf registration for nearly 9,950,000 common shares tied to an employee stock plan, reshaping its capital structure ahead of planned commercial spaceflights. These moves highlight the trade-off between near-term dilution and improved liquidity as Virgin Galactic works toward late-2026 commercial operations and seeks to...

In recent days, Nextpower has been swept up in sector-wide swings linked to shifting Iran-related geopolitical risks, which have affected solar and broader energy technology companies without any new company-specific announcements. At the same time, the company has remained a focus of investor attention with consistent earnings outperformance versus consensus, even as near-term earnings expectations and analyst sentiment have been mixed. We’ll now examine how this geopolitically driven...

SpaceX’s blockbuster IPO, with its 19% first day jump to $160 and an estimated $1.77t valuation, has pulled fresh attention toward recently listed stocks that traders see as potential momentum plays. When a headline listing captures the market’s imagination, it can spill over into other young IPOs that already show strong price moves and active trading. This article looks at 3 stocks from the IPO Momentum Stocks screener that appear closely tied to this surge in enthusiasm around newly public...

Earlier this month, Digital Turbine launched Launchpad, a unified app distribution platform that ties together carrier and OEM integrations, SingleTap installs, direct app relationships, and a footprint of more than 82,000 apps across over 1.00 billion devices to power modern app discovery and installs. The platform is already being used by game developers such as Zynga, Playtika, King and mobile partners including Orange, Motorola, and Telefónica, highlighting how on-device distribution and...

With inflation running at 4.2% on CPI, 6.5% on PPI and rate markets now pricing in a possible hike rather than cuts, income investors are suddenly playing a different game. Higher yields and a firm labor market can reward companies that already generate solid cash flow, carry manageable debt and keep dividends on a realistic footing. This article focuses on three stocks from a High Quality Dividend Stocks screener that fit that description and are directly exposed to the current interest rate...

Why W. R. Berkley (WRB) is Drawing Fresh Investor Attention W. R. Berkley (WRB) has been back on investors’ radar after recent trading left the stock with a mixed return profile, including a decline over the past year alongside solid multi year total returns. See our latest analysis for W. R. Berkley. Recent trading has been choppy, with a 1 day share price return of 1.08% and a 1 month share price return of 4.34%. The 1 year total shareholder return is down 4.36%, compared with much stronger...

Organon (OGN) is back in focus after the US Food and Drug Administration approved an expanded label for its tocilizumab biosimilar, TOFIDENCE, adding indications for severe cytokine release syndrome and certain hospitalized COVID-19 patients. See our latest analysis for Organon. At a latest share price of US$13.44, Organon’s 90 day share price return of 111.65% and year to date share price return of 85.64% contrast with a 3 year total shareholder return that declined 27.03%. This suggests...

Apple (AAPL) is back in focus after its Worldwide Developers Conference, where the company revealed a revamped Siri AI and broader Apple Intelligence rollout, only to see the stock sell off on investor disappointment. See our latest analysis for Apple. The stock reaction around WWDC has been choppy, with a 1-day share price return of down 1.52% and a 7-day share price return of down 5.27% as investors reassessed the impact of Siri AI and Apple Intelligence. This is occurring even though the...

Macy’s, Inc. recently reported first-quarter 2026 results, with revenue of US$4,892 million and net income of US$63 million, and modestly raised its full-year net sales guidance to US$21.5 billion–US$21.75 billion, while also updating its ongoing share repurchase activity. Following these updates, several Wall Street firms upgraded their outlook on Macy’s turnaround efforts, highlighting improving operations even as some insiders sold shares and the company continues to face store closures...

Genuine Parts recently announced plans, following pressure from activist investor Elliott, to split by early 2027 into two independent publicly traded companies focused on Global Automotive and Global Industrial operations. The move aims to unlock value by giving each business a clearer identity and investor base, but raises questions around separation costs, potential dis-synergies, and how the future dividend policy will be structured across the two entities. We will now explore how the...

Understanding DRDGOLD’s recent move DRDGOLD (DRD) recently drew attention after a one day gain of 2.27%, standing out against a period where the stock is down about 21% over the past month and 22% over the past 3 months. See our latest analysis for DRDGOLD. Despite the latest one day share price gain, DRDGOLD’s recent momentum has been fading, with the share price down over the past month and year to date, while the 1 year and multi year total shareholder returns remain strongly positive. If...

Ford Motor (F) is back in focus after enthusiasm around its Ford Energy battery storage unit and the restart of a key aluminum supplier, developments that follow strong earnings and rising earnings estimates. See our latest analysis for Ford Motor. Ford’s recent momentum is clear, with a 30 day share price return of 9.36% and a 90 day share price return of 27.16%. The 1 year total shareholder return of 49.30% reflects how earnings, Ford Energy headlines, and improving aluminum supply are...

Event context and recent stock move Covenant Logistics Group (CVLG) stock has drawn attention after a recent move that left shares at US$45.45, with the price higher over the past week, month and past 3 months. See our latest analysis for Covenant Logistics Group. The recent 1-day share price pullback of 1.88% comes after strong momentum, with a 30-day share price return of 42.25% and a 1-year total shareholder return of 101.74%. This indicates sentiment has strengthened over both short and...

LivaNova PLC recently elected experienced global executive Jette Nygaard-Andersen to its Board of Directors and appointed Anne Liddy as Chief Legal Officer, while long-serving director Dr. Sharon O’Kane stepped down after a decade on the Board. These governance changes bring fresh expertise in medtech, legal and compliance oversight, and executive leadership, potentially influencing how LivaNova manages regulatory complexity and long-term corporate priorities. We’ll now examine how adding...

Core & Main (CNM) is back in focus after first quarter results topped earnings expectations, municipal demand held up against weak residential construction, and management reaffirmed full year guidance while expanding its share repurchase authorization. See our latest analysis for Core & Main. The latest earnings beat and guidance reaffirmation come after a year where the share price has eased, with a year-to-date share price return of down 9.51%. The 3-year total shareholder return of 69.16%...

In recent days, Silgan Holdings Inc. participated in a broad rally across the packaging sector, as investors showed increased interest in rigid packaging suppliers serving food, beverage, and household product markets. Amid this sector-wide momentum, Silgan’s above-average forward dividend yield and record of consistent dividend growth are drawing attention from income-focused and value-oriented investors weighing its risk profile. We’ll now explore how this sector-wide interest, alongside...

Denali Therapeutics (DNLI) stock has been in focus after the company and Biogen halted the Phase 2b LUMA trial of BIIB122 for idiopathic Parkinson’s disease, following missed primary and secondary efficacy endpoints. For investors, attention now shifts to Denali’s planned independent Phase 2a BEACON trial in genetically targeted Parkinson’s patients. This keeps BIIB122 in the pipeline but with a narrower, more focused development path. See our latest analysis for Denali Therapeutics. At a...

Star Bulk Carriers recently drew attention with upbeat analyst expectations for significant year-over-year earnings growth and a Zacks Rank #1 (Strong Buy), alongside an upcoming US$0.50 per-share dividend that went ex-dividend on June 12, 2026. This positive outlook has emerged even as Director Nikolaos Karellis sold 20,000 shares on June 11, 2026, completing a year of exclusively insider selling activity. Next, we’ll examine how the bullish earnings revisions, despite ongoing insider...

In recent months, General Mills has faced weakening volumes across key brands, pressure on its North America Retail and Pet segments, and rising concern about debt and dividend coverage, while appointing Dana McNabb as chief operating officer to address these operational challenges. This combination of softer demand, elevated leverage, and leadership change is prompting investors to reassess how durable General Mills’ margins and payout policies may be. We’ll now examine how the new COO...

In recent days, Seagate Technology Holdings reported surging AI-related demand for its HAMR-based Mozaic drives, raised its long-term annual revenue growth target to at least 20%, and moved to redeem its 3.50% Exchangeable Senior Notes due 2028, tightening its balance sheet after eliminating about US$150.70 million of debt. Multi-year agreements that have nearline capacity almost fully allocated through 2027, combined with very large 12‑month stock gains and insider share sales, highlight...